Pink Sheet is part of the Informa Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Trans Fat Footnote Statement On Food, Supplement Labeling Proposed By FDA

This article was originally published in The Tan Sheet

Executive Summary

FDA is seeking comments on the proposed use of a footnote statement on food and dietary supplement products containing trans fat that would advise consumers against excessive intake of the ingredient
Advertisement

Related Content

Supplement Trans Fat Label Additions Stipulated Under FDA Final Rule
Supplement Trans Fat Label Additions Stipulated Under FDA Final Rule
Supplement Trans Fat Label Additions Stipulated Under FDA Final Rule
Food, Supplement Trans Fat Footnote Consumer Research Urged By FTC
Food, Supplement Trans Fat Footnote Consumer Research Urged By FTC
Food, Supplement Trans Fat Footnote Consumer Research Urged By FTC
Trans fat reg
Trans fatty acids

Topics

Advertisement
UsernamePublicRestriction

Register

PS094804

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel